Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "ARI"

3786 News Found

Hikal swings back to profit in Q4 FY26 despite regulatory hit & strategic charges
News | May 28, 2026

Hikal swings back to profit in Q4 FY26 despite regulatory hit & strategic charges

Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments


Organ Man of India Nilesh Mandlewala bestowed with Padma Shri
Healthcare | May 28, 2026

Organ Man of India Nilesh Mandlewala bestowed with Padma Shri

Honoured for his immense contribution in the field of social service and organ donation awareness


India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade
Policy | May 28, 2026

India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade

As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly


Gandhar Oil posts robust FY26 profit
News | May 28, 2026

Gandhar Oil posts robust FY26 profit

PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion


Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Biopharma | May 28, 2026

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress


Glenmark Pharma appoints Shisher Chowksey as Head of Marketing
People | May 27, 2026

Glenmark Pharma appoints Shisher Chowksey as Head of Marketing

In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth


Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
News | May 27, 2026

Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention

Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.


Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
Clinical Trials | May 26, 2026

Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy

A one-shot gene-editing cholesterol therapy could soon be a reality


International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth
News | May 26, 2026

International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth

Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023


China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
Drug Approval | May 26, 2026

China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer

The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer